Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer von Andre, T, Shiu, K.-K, Kim, T.W, Jensen, B, Jensen, L.H, Punt, C, Smith, D, Garcia-Carbonero, R, Benavides, M, Gibbs, P, de la Fouchardiere, C, Rivera, F, Elez, E, Bendell, J, Le, D.T, Yoshino, T, Van Cutsem, E, Yang, P, Farooqui, M.Z.H, Marinello, P, Diaz, L.A

Volltext

396O Health-related quality of life (HRQoL) in patients (pts) treated with pembrolizumab (pembro) vs chemotherapy as first-line treatment in microsatellite instability-high (MSI-H)... von André, T., Amonkar, M., Norquist, J., Shiu, K-K., Kim, T.W., Jensen, B.V., Jensen, L.H., Punt, C.J., Smith, D., Garcia-Carbonero, R., Sevilla, I., Fouchardiere, C. de la, Rivera, F., Elez, E., Diaz, L.A., Yoshino, T., Van Cutsem, E., Yang, P., Farooqui, M.Z.H., Le, D.

Volltext